In today’s session iKang Healthcare Group Inc (ADR) (KANG) registered an unusually high (161) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious KANG increase. With 161 contracts traded and 34604 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: KANG161216C00017500 closed last at: $0.8 or 23.1% up. About 31,816 shares traded hands. iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) has declined 18.83% since April 20, 2016 and is downtrending. It has underperformed by 23.39% the S&P500.
According to Zacks Investment Research, “iKang Healthcare Group, Inc. is engaged in providing preventive healthcare solutions in the People’s Republic of China. It offers medical examination, screening and other services. The Company primarily serves corporate and individual customers. It provides its services through self-owned medical centers and the facilities of third-party service providers. iKang Healthcare Group, Inc. is headquartered in Beijing, the People’s Republic of China.”
iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The company has a market cap of $1.20 billion. The Company’s divisions include medical examinations and other medical services, and dental services. It has a 91 P/E ratio.
KANG Company Profile
iKang Healthcare Group, Inc., incorporated on May 25, 2011, provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Firm operates through two divisions: medical examinations and other medical services, and dental services. As of March 31, 2016, its network across the nation consisted of 86 self-owned medical centers, and its self-owned medical center network covered 25 cities in China, such as Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Changchun, Jiangyin, Changzhou, Shenyang, Changsha, Wuhan, Yinchuan, Yantai, Weihai, Weifang, Foshan, Xi’an, Wuhu and Guiyang, as well as Hong Kong. The Company’s network across the nation offers a range of medical examination services and provides a one-stop solution to its corporate customers.
More notable recent iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) news were published by: Quotes.Wsj.com which released: “DOW JONES, A NEWS CORP COMPANY” on April 06, 2014, also Bloomberg.com with their article: “China’s IKang Rises to Seven-Month High as Bidding War Heats Up” published on January 06, 2016, Barrons.com published: “iKang’s Vital Signs Strong in China’s Testing Boom” on December 04, 2014. More interesting news about iKang Healthcare Group Inc (ADR) (NASDAQ:KANG) were released by: Bloomberg.com and their article: “Tybourne Among Asia Hedge Funds Selling Chinese Company ADRs” published on February 19, 2016 as well as Reuters.com‘s news article titled: “iKang Healthcare Group Inc mGuizhou Wishstar Medical Center” with publication date: March 23, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.